1. Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria

   • Seiko Iki
   • Kazuyuki Ohgi
   • Kenshi Suzuki

   Images in Hematology 21 November 2016 Pages: 231 - 232

   

2. Haemolysis in female patient with chronic phase CML

   • Silvia Lovato
   • Robert Ayto

   Images in Hematology 17 November 2016 Pages: 233 - 234

   

3. The initiation and effects of plasma contact activation: an overview

   • Lisha Lin
   • Mingyi Wu
   • Jinhua Zhao

   Review Article 15 November 2016 Pages: 235 - 243

   

4. Tumor vascular infarction: prospects and challenges

   • Rana Jahanban-Esfahlan
   • Khaled Seidi
   • Nosratollah Zarghami

   Review Article 02 January 2017 Pages: 244 - 256

   

5. Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?

   • Erden Atilla
   • Pinar Ataca Atilla
   • Taner Demirer

   Review Article 19 December 2016 Pages: 257 - 264

   

6. Characterization of circulating CD4⁺ CD8⁺ double positive and CD4⁻ CD8⁻ double negative T-lymphocyte in children with β-thalassemia major

   • Asmaa M. Zahran
   • Khaled Saad
   • Mohamd A. Alblihed

   Original Article 15 November 2016 Pages: 265 - 271

   

7. High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism

   • Makoto Ikejiri
   • Hideo Wada
   • Masaaki Ito

   Original Article 20 October 2016 Pages: 272 - 279

   

8. Analysis of the Japanese subgroup in LEOPOLD II: a phase 2/3 study of BAY 81-8973, a new recombinant factor VIII product

   • Teruhisa Fujii
   • Hideji Hanabusa
   • Katsuyuki Fukutake

   Original Article 10 November 2016 Pages: 280 - 286

   

9. Causative genetic mutations for antithrombin deficiency and their clinical background among Japanese patients

   • Akiko Sekiya
   • Fumina Taniguchi
   • Eriko Morishita

   Original Article 17 November 2016 Pages: 287 - 294

   

10. Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis

    • Sohsuke Meshitsuka
    • Sumito Shingaki
    • Kenshi Suzuki

    Original Article 04 November 2016 Pages: 295 - 308

    

11. Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis

    • Norio Komatsu
    • Keita Kirito
    • Koichi Akashi

    Original Article 10 November 2016 Pages: 309 - 317

    

12. Human MutT homologue 1 mRNA overexpression correlates to poor response of multiple myeloma

    • Huixing Zhou
    • Yuan Jian
    • Wenming Chen

    Original Article 15 November 2016 Pages: 318 - 325

    

13. Elotuzumab with lenalidomide and dexamethasone for Japanese patients with relapsed/refractory multiple myeloma: phase 1 study

    • Shinsuke Iida
    • Hirokazu Nagai
    • Takaaki Chou

    Original Article 15 November 2016 Pages: 326 - 334

    

14. Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia

    • Makiko Morita
    • Yoko Nishinaka
    • Souichi Adachi

    Original Article 15 November 2016 Pages: 335 - 340

    

15. Bortezomib–dexamethasone versus high-dose melphalan for Japanese patients with systemic light-chain (AL) amyloidosis: a retrospective single-center study

    • Nagaaki Katoh
    • Akihiro Ueno
    • Shu-ichi Ikeda

    Original Article 10 November 2016 Pages: 341 - 348

    

16. A questionnaire survey on attitude toward sperm cryopreservation among hematologists in Japan

    • Tomohiro Kobayashi
    • Takeshi Shin
    • Hiroshi Okada

    Original Article 14 November 2016 Pages: 349 - 352

    

17. Iron overload patients with unknown etiology from national survey in Japan

    • Katsuya Ikuta
    • Mayumi Hatayama
    • Yutaka Kohgo

    Original Article 15 November 2016 Pages: 353 - 360

    

18. Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation

    • Kimitaka Suetsugu
    • Hiroaki Ikesue
    • Satohiro Masuda

    Original Article 07 November 2016 Pages: 361 - 368

    

19. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation

    • Ryoji Kobayashi
    • Tetsuo Mitsui
    • Junji Suzumiya

    Original Article 27 October 2016 Pages: 369 - 376

    

20. Pediatric intestinal Behçet disease complicated by myeloid malignancies

    • Kiichiro Kanamitsu
    • Akira Shimada
    • Atsushi Manabe

    Original Article 15 November 2016 Pages: 377 - 382

    

21. Fulminant type I diabetes mellitus associated with nivolumab in a patient with relapsed classical Hodgkin lymphoma

    • Wataru Munakata
    • Ken Ohashi
    • Kensei Tobinai

    Case Report 01 October 2016 Pages: 383 - 386

    

22. Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis

    • Norio Komatsu
    • Keita Kirito
    • Koichi Akashi

    Erratum 07 February 2017 Pages: 387 - 387